Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from diabetes

News of a ‘giant’ baby boy is all over TikTok. Here’s what women really need to know

Baby boy Cassian is an internet sensation. He was born earlier this year in the United States weighing 5.8 kilograms. But after his mum and the hospital shared the news recently, it wasn’t long before headlines about the “giant” baby spread around the world. These included:

The Conversation

Biomea Fusion Stock Plummets Following Public Offering, Diabetes Study

Biomea Fusion Inc‘s (NASDAQ:BMEA) stock price plummeted after the company priced its public offering.

Benzinga

Costco to start selling Ozempic and Wegovy at discounted prices

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Where in Europe is diabetes most prevalent?

A recent report has found that some 66 million European adults suffer from diabetes. This number is set to increase by another 10% by 2050.

Euronews

Millions use wearable devices to track their blood sugar. But they don’t help everyone

The devices have surged in popularity among people without diabetes, but a study suggests reality may not match the hype.

Euronews

Fruit, veg and nut diet ‘could prevent around 15 million deaths globally’

Experts say the planetary health diet is linked to a 27% reduced risk of premature death and fewer cases of diabetes, cancer and heart disease.

Evening Standard

Breastfeeding is ideal for child and parent health but challenging for most families – a pediatrician explains how to find support

As a pediatrician, I thought my medical background and pediatric training meant I would be well prepared to breastfeed my newborn. I knew all about the research on how an infant’s diet can affect both their short- and long-term health. Compared to formula, breastfeeding is linked to a lower risk…

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Genetic condition raises diabetes complication risk in black and South Asian men

Researchers estimate around one in seven black men and one in 63 South Asian men are affected, compared with fewer than one in 100,000 white men.

Evening Standard

Prediabetes remission possible without dropping pounds, our new study finds

There’s a long-held belief in diabetes prevention that weight loss is the main way to lower disease risk. Our new study challenges this.

The Conversation

US refuses to back UN declaration on noncommunicable diseases

General assembly backs new targets on cancer, diabetes and heart disease but Robert F Kennedy Jr objects

The Guardian - UK

Zika virus may raise long-term risks of type 2 diabetes – new study

It has been ten years since Brazil faced a major outbreak of the Zika virus. The alert was given in 2015, when the country’s north-eastern states reported a sudden increase in the number of babies born with unusually small heads – a condition called microcephaly.

The Conversation

‘Exciting’ clinical results offer hope for new class of MS therapies

Cambridge trial suggests diabetes drug with antihistamine can partially repair damage in the nervous system

The Guardian - UK

Eli Lilly Stock Is Trading Down Thursday: What's Behind The Move?

Eli Lilly and Company (NYSE: LLY) shares are trading lower after the company ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began. The termination is a setback for Lilly’s obesity pipeline among growing investor expectations.

Benzinga

Not all diabetes is about sugar – understanding diabetes insipidus

Diabetes mellitus – known to many as type 1 and type 2 diabetes – gets all the attention with its rising global prevalence and connection to lifestyle and autoimmunity. Meanwhile, its lesser-known relative – diabetes insipidus – more quietly affects hundreds of thousands of people worldwide, but is an altogether…

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Eli Lilly Ends Bimagrumab Obesity Study Weeks After Launch

On Wednesday, Eli Lilly Co. (NYSE: LLY) ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began.

The Conversation

Gestational diabetes linked to autism and ADHD in new study

A major new analysis is drawing fresh attention to the possible links between gestational diabetes and long-term brain health in both mothers and their children. The review, which combined data from 48 studies conducted over nearly 50 years, suggests that diabetes during pregnancy may have effects that extend well beyond…

The Independent UK

Scientists surprised to find human body makes its own Ozempic version

Study finds body’s ‘built-in backup plan’ for diabetes-controlling hormone production

Bored Panda

Doctors Sound Alarm Over Concerning Cause Behind Rise In Giant Baby Births

"Whose baby is this? He came out of me?"

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Could This New Drug Be The Safer Way To Fight Obesity?

On Friday, Skye Bioscience, Inc. (NASDAQ:SKYE) announced the presentation of results from the Phase 1b study of nimacimab in subjects with metabolic-associated steatotic liver disease (MASLD) at the European Association for the Study of Diabetes (EASD) Annual Meeting.

The Independent UK

Daily arthritis pill could slow progression of diabetes, trial finds

The drug is already used to treat several autoimmune diseases, including rheumatoid arthritis, ulcerative colitis, and alopecia

Benzinga

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device.

Euronews

New AI tool predicts risk of more than 1,000 medical conditions a decade in advance

The model can accurately predict conditions such as diabetes and cancer, and is less reliable for issues such as infectious diseases and mental health disorders.

The Independent UK

New type of jab helps to maintain weight loss

Experts have developed a new drug which helps tackle the underlying causes of obesity.

Benzinga

Could This Eli Lilly Oral Pill Be Key To Significant Weight Loss?

Eli Lilly and Co (NYSE:LLY) on Tuesday shared detailed results from the Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of oral orforglipron in adults with obesity, or overweight with a weight-related medical problem, and without diabetes.

The Conversation

Serious mental illness often brings rapid weight gain – but support is missing

Being diagnosed with a serious mental illness like schizophrenia or bipolar disorder often brings an overlooked challenge: rapid and sustained weight gain. This side-effect can raise the risk of diabetes, heart disease and early death – widening an already stark life expectancy gap.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Exeter

Science Photo Library

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.